MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$41,206K
EPS
-$0.55
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
43,257
29,145
21,314*
28,988
General and administrative
6,850
7,289
7,223*
5,117
Total operating expenses
50,107
36,434
28,536
34,105
Loss from operations
-50,107
-36,434
-28,536*
-34,105
Interest income
8,897
4,606
5,097*
3,832
Other expense, net
-
-
-
4
Other income (expense), net
4
8
-3*
-
Total other income, net
8,901
4,614
5,094*
3,828
Net loss
-41,206
-31,820
-23,443
-30,277
Net change in unrealized gains (losses) on marketable securities
-
-
-
212
Comprehensive loss
-
-
-
-30,065
Basic EPS
-0.55
-0.48
-0.463
-0.55
Diluted EPS
-0.55
-0.48
-0.463
-0.55
Basic Average Shares
62,872,318
55,172,410
50,679,416
44,067,059
Diluted Average Shares
62,872,318
55,172,410
50,679,416
44,067,059
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ORKA Income Statement Sankey Diagram
Sankey diagram visualizing ORKA income statement for the period
Interest income
$8,897K
(130.67%↑ Y/Y)
Other income
(expense), net
$4K
Net loss
-$41,206K
(-67.68%↓ Y/Y)
Total other income,
net
$8,901K
(130.89%↑ Y/Y)
Loss from operations
-$50,107K
(-76.25%↓ Y/Y)
Total operating
expenses
$50,107K
(76.25%↑ Y/Y)
Research and development
$43,257K
(79.59%↑ Y/Y)
General and
administrative
$6,850K
(57.76%↑ Y/Y)
Buy us a coffee
Oruka Therapeutics, Inc. (ORKA)
Oruka Therapeutics, Inc. (ORKA)